Cardiac Critical Care After Transcatheter Aortic Valve Replacement

Cardiology Clinics

Volumn 31, Issue 4, 2013, Pages 607-618

  Tomey, Matthew I ^a   Gidwani, Umesh K ^a   Sharma, Samin K ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Critical care; TAVR; Transcatheter aortic valve replacement

Indexed keywords

ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; ANEMIA; AORTA STENOSIS; BLOOD VESSEL INJURY; CARDIAC CRITICAL CARE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; ENTERIC FEEDING; FEVER; FLUID RESUSCITATION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEMODYNAMICS; HUMAN; HYPOTENSION; INTENSIVE CARE; LEUKOCYTOSIS; MALNUTRITION; NUTRITIONAL STATUS; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; VASCULAR DISEASE; VENTILATOR; VULNERABLE POPULATION;

COMPLICATIONS; CRITICAL CARE; TAVR; TRANSCATHETER AORTIC VALVE REPLACEMENT;

ANEMIA; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COMMUNICATION; CRITICAL CARE; FEEDING METHODS; FEVER; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; HYPOTENSION; INTERPROFESSIONAL RELATIONS; LEUKOCYTOSIS; PATIENT CARE TEAM; PROSTHESIS DESIGN; RECURRENCE; STROKE; VENTILATOR WEANING;

EID: 84887000404     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2013.07.006     Document Type: Review

References (50)

1. Kodali S.K., Williams M.R., Smith C.R., et al. Two-year outcomes after transcatheter or surgical aortic valve replacement. NEngl J Med 2012, 366:1686-1695.
2. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. NEngl J Med 2010, 363(17):1597-1607.
3. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. NEngl J Med 2011, 364(23):2187-2198.
4. van Mieghem N.M., Head S.J., van der Boon R.M., et al. The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention 2012, 8(2):258-266.
5. Gilard M., Eltchaninoff H., Iung B., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. NEngl J Med 2012, 366(18):1705-1718.
6. Webb J.G., Wood D.A. Current status of transcatheter aortic valve replacement. JAm Coll Cardiol 2012, 60(6):483-492.
7. Généreux P., Head S.J., Wood D.A., et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J 2012, 33:2388-2398.
8. Saia F., Marrozzini C., Moretti C., et al. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention 2011, 7(6):723-729.
9. Giannini C., Petronio A.S., De Carlo M., et al. The incremental value of valvuloarterial impedance in evaluating the results of transcatheter aortic valve implantation in symptomatic aortic stenosis. JAm Soc Echocardiogr 2012, 25:444-453.
10. Rajappan K., Rimoldi O.E., Camici P.G., et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 2003, 107:3170-3175.
11. López Ayerbe J., Evangelista Masip A., Armada Romero E., et al. Predictive factors of abnormal dynamic intraventricular gradient after valve replacement in severe aortic stenosis. Rev Esp Cardiol 2002, 55:127-134.
12. Suh W.M., Witzke C.F., Palacios I.F. Suicide left ventricle following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010, 76:616-620.
13. Zhu F., Lee A., Chee Y.E. Fast-track cardiac care for adult cardiac surgical patients. Cochrane Database Syst Rev 2012, (10). CD003587.
14. Higgins T.L. Pro: early endotracheal extubation is preferable to late extubation in patients following coronary artery surgery. JCardiothorac Vasc Anesth 1992, 6:488-493.
15. Siliciano D. Con: early extubation is not preferable to late extubation in patients undergoing coronary artery surgery. JCardiothorac Vasc Anesth 1992, 6:494-498.
16. Hawkes C., Foxcroft D.R., Yerrell P. Clinical guideline for nurse-led early extubation after coronary artery bypass: an evaluation. JAdv Nurs 2010, 66:2038-2049.
17. Visvanathan R., Newbury J.W., Chapman I. Malnutrition in older people: screening and management strategies. Aust Fam Physician 2004, 33(10):799-805.
18. Engelman D.T., Adams D.H., Byrne J.G., et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. JThorac Cardiovasc Surg 1999, 118:866-873.
19. Thourani V.H., Keeling W.B., Kligo P.D., et al. The impact of body mass index on morbidity and short- and long-term mortality in cardiac valvular surgery. JThorac Cardiovasc Surg 2011, 142(5):1052-1061.
20. Green P., Woglom A.E., Genereux P., et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis. JACC Cardiovasc Interv 2012, 5(9):974-981.
21. Hummell A.C. Nutrition for the critically ill cardiac and thoracic patient. Nutrition support for the critically ill patient: a guide to practice 2005, 519-527. CRC Press, Boca Raton (FL). G. Cresci (Ed.).
22. Leon M.B., Piazza N., Nikolsky E., et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. JAm Coll Cardiol 2011, 57:253-269.
23. Tchetche D., van der Boon R.M., Dumontell N., et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation. Am Heart J 2012, 164(3):402-409.
24. Genereux P., Head S.J., Van Mieghem N.M., et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 19 studies. JAm Coll Cardiol 2012, 59:2317-2326.
25. Loscalzo J. From clinical observation to mechanism-Heyde's syndrome. NEngl J Med 2012, 367:1954-1956.
26. Vincentelli A., Sesen S., Le Tourneau T., et al. Acquired von Willebrand syndrome in aortic stenosis. NEngl J Med 2003, 349:343-349.
27. Bander J., Elmariah S., Aledort L.M., et al. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty. Thromb Haemost 2012, 108(1):86-93.
28. Godino C., Lauretta L., Pavon A.G., et al. Heyde's syndrome incidence and outcome in patients undergoing transcatheter aortic valve implantation. JAm Coll Cardiol 2013, 61(6):687-689.
29. Carson J.L., Terrin M.L., Noveck H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. NEngl J Med 2011, 365(26):2453-2462.
30. Franzoni I., Latib A., Chieffo A., et al. Fever after TAVI: infection or inflammation?. EuroIntervention 2012, 8(Suppl N):351.
31. Van Mieghem N.M., van der Boon R.M., Nuis R.J., et al. Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2012, 10.1002/ccd.24597.
32. Onsea K., Agostoni P., Voskuil M., et al. Infective complications after transcatheter aortic valve implantation: results from a single centre. Neth Heart J 2012, 20(9):360-364.
33. Nuis R.J., Van Mieghem N.M., Schultz C.J., et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 2012, 109(1):1637-1643.
34. Ghanem A., Müller A., Nähle C.P., et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. JAm Coll Cardiol 2010, 55(14):1427-1432.
35. Drews T., Pasic M., Buz S., et al. Trancranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg 2011, 59:237-242.
36. Daneault B., Kirtane A.J., Kodali S.K., et al. Stroke associated with surgical or transcatheter treatment of aortic stenosis. JAm Coll Cardiol 2011, 58:2143-2150.
37. Natorska J., Marek G., Hlawaty M., et al. Evidence for tissue factor expression in aortic valves in patients with aortic stenosis. Pol Arch Med Wewn 2009, 119(10):636-643.
38. Natorska J., Marek G., Hlawaty M., et al. Fibrin presence within aortic valves in patients with aortic stenosis: association with invivo thrombin generation and fibrin clot properties. Thromb Haemost 2011, 105(2):254-260.
39. Grube E., Naber C., Abizaid A., et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 2011, 4(7):751-757.
40. Nietlispach F., Wijesinghe N., Gurvitch R., et al. Anembolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010, 3:1133-1138.
41. Rodés-Cabau J., Dauerman H.L., Cohen M.G., et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. JAm Coll Cardiol 2013, 10.1016/j.jacc.2013.03.029.
42. Amat-Santos I.J., Rodés-Cabau J., Urena M., et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. JAm Coll Cardiol 2012, 59(2):178-188.
43. Dewilde W.J., Oirbans T., Verheught F.W., et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomized, control trial. Lancet 2013, 381(9872):1107-1115.
44. Zeymer U., Zahn R., Gerckens U., et al. Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J 2011, 32(Suppl):900. [abstract].
45. Piazza N., Onuma Y., Jesserun E., et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008, 1(3):310-316.
46. Godin M., Eltchaninoff H., Furuta A., et al. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 2010, 106(5):707-712.
47. Kong W.Y., Yong G., Irish A. Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology (Carlton) 2012, 17(5):445-451.
48. Barbash I.M., Ben-Dor I., Dvir D., et al. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 2012, 163(6):1031-1036.
49. Wendler O., MacCarthy P. Renal failure after tavi-do we know the full story?. JAm Coll Cardiol 2013, 10.1016/j.jacc.2013.04.058.
50. Scheiger M.J., Chambers C.E., Davidson C.J., et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007, 69(1):135-140.